IP Library Granted Patent US 7,927,619
Granted Patent B2
US 7,927,619 · App. 11/411,283 · Granted Apr 19, 2011

In situ bulking composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,927,619
App. No.
11/411,283
Granted
Apr 19, 2011
Kind
B2
Abstract

The present invention relates to a hydrated, biocompatible tissue-augmentation compound and methodology for its implantation into mammalian tissue. The tissue-augmentation compound is comprised of: living tissue, optionally body derived fluids, and at least one NCO-terminated hydrophilic urethane prepolymer derived from an organic polyisocyanate, and oxyethylene-containing diols or polyols in which essentially all of hydroxyl groups are capped with polyisocyanate.

Claims (10)

1. A method of preparing a crosslinked hydrophilic, biocompatible hydrated tissue-augmentation compound by reacting together mammalian body tissue, body derived fluids and a prepolymer in a prepolymer-to-water ratio of 3:1 to 1:20, said prepolymer prepared by the steps of:

(a) Selecting diols or polyols from oxyethylene-based diols or polyols having an average molecular weight of 3,000 to about 30,000, and

(b) Reacting said diols or polyols with an aliphatic or aromatic polyisocyanate at an isocyanate-to-hydroxyl ratio of about 2.0 to about 2.5 so that all of the hydroxyl groups of said diols or polyols are capped with polyisocyanate and the resulting prepolymer has an isocyanate concentration of no more than 0.8 milliequivalents per gram.

2. The method of claim 1 wherein said diols or polyols are oxyethylene-based diols or polyols containing no more than about 30% by number of propylenes oxide subunits.

3. The method of claim 1 wherein said diols and polyols of step (a) are dissolved in an organic solvent selected from the group comprising acetonitrile or acetone.

4. The method of claim 1 which includes a solution of non-body derived water, including a saline solution containing 0.9% NaCl.

5. The method of claim 4 wherein the solution of non-body derived water comprises a substantially isotonic saline solution.

6. The method of claim 1 further including the step of washing the bond with a polyamine to end isocyanate reactivity.

7. The method of claim 1 , further including the step of

heating said compound to a temperature to between about 65-80 degrees C.; and adding said heated compound to mammalian body tissue.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2007
From: MILBOCKER, MICHAEL T.
To: PROMETHEAN SURGICAL DEVICES
Reel/Frame 019372/0084 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2007
From: MILBOCKER, MICHAEL T.
To: PROMETHEAN SURGICAL DEVICES
Reel/Frame 019372/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2007
From: MILBOCKER, MICHAEL T.
To: PROMETHEAN SURGICAL DEVICES
Reel/Frame 019372/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2007
From: MILBCOKER, MICHAEL T.
To: PROMETHEAN SURGICAL DEVICES
Reel/Frame 019372/0370 →